User menu

Cinacalcet HCl controls secondary hyperparathyroidism (HPT) regardless of gender, race, age, and geography in patients with chronic kidney disease (CKD) receiving dialysis.

Bibliographic reference Coyne, DW ; Jadoul, Michel ; Stegman, MH ; Azad, H ; Joy, MS ; et. al. Cinacalcet HCl controls secondary hyperparathyroidism (HPT) regardless of gender, race, age, and geography in patients with chronic kidney disease (CKD) receiving dialysis..36th Annual Meeting of the American-Society-of-Nephrology (SAN DIEGO (California), Nov 12-17, 2003). In: Journal of the American Society of Nephrology, Vol. 14, p. 464A-464A (2003)
Permanent URL http://hdl.handle.net/2078.1/61340